Abstract | OBJECTIVE: METHODS: RESULTS:
IgG, IgM, and IgA anti-beta2-GPI were positive in 38.1, 13.7, and 34.8% of patients, respectively. Patients with a history of thrombosis were significantly more likely to have lupus anticoagulant (LAC), IgG aCL, and the 3 anti-beta2-GPI isotypes. Arterial thrombosis was associated with the presence of IgG aCL and the 3 anti-beta2-GPI isotypes, whereas venous thrombosis was associated with LAC, IgG aCL, and IgA anti-beta2-GPI. In stepwise multivariate logistic regression analysis, the variable that was associated with thrombosis was IgA anti-beta2-GPI. The occurrence of arterial thrombosis was associated with IgG aCL and that of venous thrombosis was related to IgA anti-beta2-GPI in stepwise multivariate analysis. The IgG, IgM, and IgA anti-beta2-GPI titers were closely correlated with IgG aCL titers. The IgA anti-beta2-GPI titers were also significantly correlated with those of IgG and IgM anti-beta2-GPI. CONCLUSION: The results suggest that anti-beta2-GPI isotypes are related to the occurrence of thrombosis, and measurements of IgA anti-beta2-GPI may be useful for predicting thrombotic episodes in patients with SLE.
|
Authors | S S Lee, M L Cho, Y S Joo, W U Kim, Y S Hong, J K Min, S H Lee, S H Park, C S Cho, H Y Kim |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 28
Issue 3
Pg. 520-4
(Mar 2001)
ISSN: 0315-162X [Print] Canada |
PMID | 11296952
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Antiphospholipid
- Glycoproteins
- Immunoglobulin A
- Immunoglobulin G
- Immunoglobulin M
- beta 2-Glycoprotein I
|
Topics |
- Antibodies, Antiphospholipid
(blood)
- Glycoproteins
(immunology)
- Humans
- Immunoglobulin A
(blood)
- Immunoglobulin G
(blood)
- Immunoglobulin M
(blood)
- Lupus Erythematosus, Systemic
(complications, immunology)
- Thrombosis
(etiology, immunology)
- beta 2-Glycoprotein I
|